SEC Comment Letter for NOVAVAX INC (NVAX) (CIK 0001000694) (NVAX) — Nov 16, 2005

NOVAVAX INC (NVAX) (CIK 0001000694)
Date: Nov. 16, 2005 · CIK: 0001000694 · Accession: 0000000000-05-058078

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-26770

Date

November 16, 2005

Author

Joel Parker

Form

UPLOAD

Company

NOVAVAX INC (NVAX) (CIK 0001000694)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 November 16, 2005 Mr. Dennis W. Genge Chief Financial Officer, Vice President Novavax, Inc. 508 Lappa Road Malvern, PA 19355

Re: Novavax, Inc. Form 10-K for Fiscal Year Ended December 31, 2004 Filed March 15, 2005 File No. 000-26770

Dear Mr. Genge,

We have completed our review of your Form 10-K and related filings and have no further comments at this time.

Sincerely,
Joel Parker
Accounting Branch Chief

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Via Facsimile and U.S. Mail
Mail Stop 6010

November 16, 2005

Mr. Dennis W. Genge
Chief Financial Officer, Vice President
Novavax, Inc.
508 Lappa Road
Malvern, PA 19355

Re:	Novavax, Inc.
	Form 10-K for Fiscal Year Ended December 31, 2004
	Filed March 15, 2005
	File No.  000-26770

Dear Mr. Genge,

      We have completed our review of your Form 10-K and related
filings and have no further comments at this time.

						Sincerely,

								Joel Parker
								Accounting Branch Chief

</TEXT>
</DOCUMENT>

SecProbe.io